Randomized Controlled Trial of the Safety and Efficacy of Daptomycin versus Standard-of-Care Therapy for Management of Patients with Osteomyelitis Associated with Prosthetic Devices Undergoing Two-Stage Revision Arthroplasty
BYREN, Ivor, REGE, Shruta, CAMPANARO, Ed, YANKELEV, Sara, ANASTASIOU, Diane, KUROPATKIN, Gennady, EVANS, Richard
Published in Antimicrobial Agents and Chemotherapy (01.11.2012)
Published in Antimicrobial Agents and Chemotherapy (01.11.2012)
Get full text
Journal Article
Safety, Pharmacokinetics, Serum Neutralizing Titers, and Immunogenicity of Adintrevimab, a Monoclonal Antibody Targeting SARS-CoV-2: A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Dose-escalation Study in Healthy Adults
Schmidt, Pete, Gong, Jean, Narayan, Kristin, Gupta, Deepali, Engler, Frank, Li, Yong, Copans, Amanda, Campanaro, Ed
Published in Infectious diseases and therapy (01.05.2023)
Published in Infectious diseases and therapy (01.05.2023)
Get full text
Journal Article
Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study of the Penetration of a Monoclonal Antibody Combination (ASN100) Targeting Staphylococcus aureus Cytotoxins in the Lung Epithelial Lining Fluid of Healthy Volunteers
Magyarics, Zoltan, Leslie, Fraser, Bartko, Johann, Rouha, Harald, Luperchio, Steven, Schörgenhofer, Christian, Schwameis, Michael, Derhaschnig, Ulla, Lagler, Heimo, Stiebellehner, Leopold, Firbas, Christa, Weber, Susanne, Campanaro, Ed, Jilma, Bernd, Nagy, Eszter, Stevens, Chris
Published in Antimicrobial agents and chemotherapy (01.08.2019)
Published in Antimicrobial agents and chemotherapy (01.08.2019)
Get full text
Journal Article
1363. Preliminary Safety Results from a Phase 1 First in Human Study of VYD222: an Extended Half-Life Monoclonal Antibody (mAb) in Development for COVID-19 Prevention
Mahoney, Kathryn, Gupta, Deepali, Li, Yong, Betancourt, Natalia, Das, Aanika, Campanaro, Ed, Schmidt, Pete
Published in Open forum infectious diseases (27.11.2023)
Published in Open forum infectious diseases (27.11.2023)
Get full text
Journal Article
226. Higher Doses of Adintrevimab, an Extended Half-Life Monoclonal Antibody, for the Treatment and Prevention of COVID-19: Preliminary Results from a Phase 1 Single Ascending-Dose Study
Pu, Xia, Gong, Jean, Campanaro, Ed, Narayan, Kristin, Gupta, Deepali, Engler, Frank, Copans, Amanda, Schmidt, Pete
Published in Open forum infectious diseases (15.12.2022)
Published in Open forum infectious diseases (15.12.2022)
Get full text
Journal Article
633. Preliminary Results from a Phase 1 Single Ascending-Dose Study Assessing Safety, Serum Viral Neutralizing Antibody Titers (sVNA), and Pharmacokinetic (PK) Profile of ADG20: an Extended Half-Life Monoclonal Antibody Being Developed for the Treatment and Prevention of Coronavirus Disease (COVID-19)
Paguntalan, Helen, Magyarics, Zoltán, Connolly, Lynn E, Hershberger, Ellie, Narayan, Kristin, Gupta, Deepali, Ambrose, Paul G, Engler, Frank, Campanaro, Ed, Das, Anita F, Schmidt, Pete
Published in Open forum infectious diseases (04.12.2021)
Published in Open forum infectious diseases (04.12.2021)
Get full text
Journal Article
Prevention of COVID-19 Following a Single Intramuscular Administration of Adintrevimab: Results From a Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial (EVADE)
Ison, Michael G, Weinstein, Debra F, Dobryanska, Marta, Holmes, Anna, Phelan, Anne-Marie, Li, Yong, Gupta, Deepali, Narayan, Kristin, Tosh, Kazima, Hershberger, Ellie, Connolly, Lynn E, Yalcin, Ilker, Campanaro, Ed, Hawn, Pamela, Schmidt, Pete
Published in Open forum infectious diseases (01.07.2023)
Published in Open forum infectious diseases (01.07.2023)
Get full text
Journal Article
Efficacy and Safety of Adintrevimab (ADG20) for the Treatment of High-Risk Ambulatory Patients With Mild or Moderate Coronavirus Disease 2019: Results From a Phase 2/3, Randomized, Placebo-Controlled Trial (STAMP) Conducted During Delta Predominance and Early Emergence of Omicron
Ison, Michael G, Popejoy, Myra, Evgeniev, Nikolay, Tzekova, Maria, Mahoney, Kathryn, Betancourt, Natalia, Li, Yong, Gupta, Deepali, Narayan, Kristin, Hershberger, Ellie, Connolly, Lynn E, Yalcin, Ilker, Das, Anita F, Genge, John, Smith, Michelle, Campanaro, Ed, Hawn, Pamela, Schmidt, Pete
Published in Open forum infectious diseases (01.06.2023)
Published in Open forum infectious diseases (01.06.2023)
Get full text
Journal Article
Efficacy and Safety of Adintrevimab (ADG20) for the Treatment of High-Risk Ambulatory Patients With Mild or Moderate COVID-19: Results From a Phase 2/3, Randomized, Placebo-Controlled Trial (STAMP) Conducted During Delta Predominance and Early Emergence of Omicron
Ison, Michael G, Popejoy, Myra, Evgeniev, Nikolay, Tzekova, Maria, Mahoney, Kathryn, Betancourt, Natalia, Li, Yong, Gupta, Deepali, Narayan, Kristin, Hershberger, Ellie, Connolly, Lynn E, Yalcin, Ilker, Das, Anita F, Genge, John, Smith, Michelle, Campanaro, Ed, Hawn, Pamela, Schmidt, Pete, Muniz, Heloísa Costa Ravagnani, Tzekova, Maria, Palaveev, Kiril, Tsenov, Vasil, Pekova, Lilia, Hadzhieva, Antoaneta, Mitreva, Roza, Nikolaev, Nikolay, Gyuzeleva, Elena, Kornmann, Marc Oliver, Schmidt, Olaf, Poulakou, Garyfalia, Milionis, Charalampos, Kofteridis, Diamantis, Dimopoulos, Meletios-Athanasios, Skopelitis, Ilias, Kotanidou, Anastasia, Tsiodras, Sotirios, Kania, Grzegorz, Grenik, Dagmara, Zajac, Tomasz, Streinu-Cercel, Anca, Pillay-Ramaya, Larisha, Mookadam, Mohamed, Mohapi, Lerato, Geldenhuys, Johan George, Vahed, Yacoob, Holmgren, Chantelle, Mekebeb-Reuter, Martha, Brumskine, William, De Jong, Douwe, Joseph, Natasha, McHarry, Kirsten, Wadvalla, Shahid, Kobrynska, Olena, Kireyev, Igor, Lebed, Kyrylo, Logoida, Pavlo, Barna, Olga, Gyrina, Olga, Gundertaylo, Bogdan, Rodionova, Viktoriia
Published in Open forum infectious diseases (24.05.2023)
Published in Open forum infectious diseases (24.05.2023)
Get full text
Journal Article